SE

Sai Eswar Rao Mahendrakar

Director Director DIN 08936221
DIN 08936221 First appointment Oct 2020 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Oct 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Sai Eswar Rao Mahendrakar

Data last updated:

Sai Eswar Rao Mahendrakar was a Director at Claro Pharmaceuticals Private Limited (2020–2022) and Director at Mrimpexo Traders Private Limited (from 2020). The companies operate in Healthcare.

DIN 08936221
Primary Designation Director
Industry Healthcare
First Appointment 27 Oct 2020
Oldest Company Age 5 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Oct 20202011₹37.4 Lakh (FY 2020)Active
Mrimpexo Traders Private Limited U51909AP2020PTC116538
Director24 Nov 20202020Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Mrimpexo Traders Private Limited
Claro Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sai Eswar Rao Mahendrakar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sai Eswar Rao Mahendrakar

Sai Eswar Rao Mahendrakar was first appointed on 27 Oct 2020 as Director at Claro Pharmaceuticals Private Limited.

Sai Eswar Rao Mahendrakar held 2 earlier board appointments: Claro Pharmaceuticals Private Limited (Director, 27 Oct 2020 to 21 Mar 2022); Mrimpexo Traders Private Limited (Director, from 24 Nov 2020).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available